CHEBI:231351 - telatinib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name telatinib
ChEBI ID CHEBI:231351
Definition A member of the class of furopyridazines that is furo[2,3-d]pyridazine substituted by (4-chlorophenyl)amino and [2-(methylcarbamoyl)pyridin-4-yl]methoxy groups at positions 4 and 7, respectively. It is a potent inhibitor of VEGFR2/3, c-Kit and PDGFRα.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Delphine Zhou
Supplier Information
Download Molfile XML SDF
Formula C20H16ClN5O3
Net Charge 0
Average Mass 409.830
Monoisotopic Mass 409.09417
InChI InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)
InChIKey QFCXANHHBCGMAS-UHFFFAOYSA-N
SMILES CNC(=O)C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=C1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): vascular endothelial growth factor receptor antagonist
An antagonist at the vascular endothelial growth factor receptor.
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing telatinib (CHEBI:231351) has role angiogenesis inhibitor (CHEBI:48422)
telatinib (CHEBI:231351) has role antineoplastic agent (CHEBI:35610)
telatinib (CHEBI:231351) has role apoptosis inducer (CHEBI:68495)
telatinib (CHEBI:231351) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434)
telatinib (CHEBI:231351) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207)
telatinib (CHEBI:231351) is a anilines (CHEBI:22562)
telatinib (CHEBI:231351) is a aromatic ether (CHEBI:35618)
telatinib (CHEBI:231351) is a furopyridazine (CHEBI:231410)
telatinib (CHEBI:231351) is a monochlorobenzenes (CHEBI:83403)
telatinib (CHEBI:231351) is a pyridinecarboxamide (CHEBI:25529)
IUPAC Name
4-({[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxy}methyl)-N-methylpyridine-2-carboxamide
INNs Sources
télatinib WHO MedNet
telatinib WHO MedNet
telatinib WHO MedNet
telatinibum WHO MedNet
Synonyms Sources
4-(((4-((4-chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide ChEBI
4-[[[4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide ChEBI
BAY 57-9352 SUBMITTER
BAY-57-9352 ChEBI
BAY-579352 ChEBI
Manual Xrefs Databases
DB15393 DrugBank
HMDB0258783 HMDB
View more database links
Registry Number Type Source
332012-40-5 CAS Registry Number SUBMITTER
Citations Waiting for Citations Types Sources
18519779 PubMed citation Europe PMC
19002179 PubMed citation Europe PMC
19636022 PubMed citation Europe PMC
19924384 PubMed citation Europe PMC
20233884 PubMed citation Europe PMC
21378200 PubMed citation Europe PMC
21801343 PubMed citation Europe PMC
24565910 PubMed citation Europe PMC
25268163 PubMed citation Europe PMC
29511030 PubMed citation Europe PMC
36171445 PubMed citation Europe PMC
Last Modified
10 May 2024